| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 8 | +50.00% | -4.37% | -0.25% | -4.12% | -1.91% | — |
| 14d | 8 | +50.00% | -8.38% | -0.80% | -7.58% | -13.58% | — |
| 30d | 8 | +62.50% | +1.05% | -1.44% | +2.49% | -0.94% | — |
| 60d | 8 | +50.00% | +7.07% | +0.72% | +6.36% | +10.26% | — |
| 90d | 8 | +62.50% | -8.20% | -1.37% | -6.83% | -15.07% | — |
| 180d | 8 | +37.50% | -7.72% | +6.95% | -14.67% | -22.93% | — |
| 1y | 8 | +50.00% | -26.02% | +16.38% | -42.40% | -48.31% | — |
| 2y | 8(6 pending) | +100.00% | +156.08% | +58.10% | +97.97% | +97.97% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| CADL CANDEL THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 7,000 | $10.02 | $70.2K | 83,865 | Jun 29, 2026 | Jul 1, 2026 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 154,000 | — | — | 154,000 | Jan 26, 2026 | Jan 28, 2026 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 5,353 | $4.67 | $25.0K | 90,865 | Jun 25, 2025 | Jun 26, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 31,278 | $8.82 | $275.9K | 85,512 | Mar 17, 2025 | Mar 20, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Technology Officer | 20,000 | — | — | 70,000 | Mar 17, 2025 | Mar 20, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Technology Officer | 20,000 | — | — | 70,000 | Mar 17, 2025 | Mar 19, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 31,278 | $8.82 | $275.9K | 85,512 | Mar 17, 2025 | Mar 19, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASE Chief Technology Officer | 20,000 | $1.29 | $25.8K | 116,790 | Mar 17, 2025 | Mar 20, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 65,000 | — | — | 65,000 | Feb 12, 2025 | Feb 14, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Technology Officer | 14,322 | $7.23 | $103.5K | 96,790 | Jan 15, 2025 | Jan 17, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Technology Officer | 14,545 | $8.22 | $119.5K | 111,112 | Jan 8, 2025 | Jan 10, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Technology Officer | 20,392 | $4.56 | $92.9K | 125,657 | Nov 29, 2024 | Dec 3, 2024 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Technology Officer | 14,851 | $6.47 | $96.1K | 146,049 | Jul 17, 2024 | Jul 19, 2024 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Technology Officer | 13,330 | $5.97 | $79.6K | 160,900 | Jul 11, 2024 | Jul 15, 2024 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Technology Officer | 17,328 | $0.90 | $15.6K | 174,230 | Nov 28, 2023 | Nov 30, 2023 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 104,516 | — | — | 191,558 | Nov 26, 2023 | Nov 28, 2023 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 90,000 | — | — | 90,000 | Apr 28, 2023 | May 2, 2023 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASE Chief Technology Officer | 10,358 | $1.93 | $20.0K | 13,358 | Dec 9, 2022 | Dec 12, 2022 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASE Chief Technology Officer | 3,000 | $1.69 | $5.1K | 3,000 | Dec 8, 2022 | Dec 12, 2022 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 73,684 | — | — | 73,684 | Nov 28, 2022 | Nov 30, 2022 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 120,000 | — | — | 120,000 | Apr 14, 2022 | Apr 15, 2022 ↗ | View → |